立体定向放疗剂量参数与早期非小细胞肺癌局部控制的相关性:1500例治疗建模研究
该建模研究合并两个回顾性数据库,分析1500例早期非小细胞肺癌立体定向放疗治疗,将PTV近最小剂量、PTV 1%近最大剂量及两者平均值转换为生物有效剂量,用Cox回归等分析其与局部复发的相关性。结果显示BEDave与肿瘤控制概率相关性最佳,提示可关注大体肿瘤体积内平均剂量而非PTV覆盖剂量。
要点
- BEDave与局部肿瘤控制概率的相关性优于BEDmax和BEDmin。
- BEDave与大体肿瘤体积平均剂量高度相关,后者或可作为处方目标。
- 应更重视达到足够高的大体肿瘤体积平均剂量而非PTV覆盖剂量。
核心结论
- BEDave与肿瘤控制概率的相关性总体优于BEDmax或BEDmin。
研究设计与样本
- 合并两个回顾性数据库,共纳入1500例接受SBRT的非小细胞肺癌治疗,来自1434例患者。
- 将PTV近最小剂量、PTV 1%近最大剂量及两者平均值转换为生物有效剂量,通过Cox回归与局部复发风险相关分析。
- 采用逻辑回归和快速节俭树进行基于BED的局部复发预测,并用Akaike信息准则比较模型。
主要发现
- 1500例治疗中117个肿瘤出现局部复发。
- 12个月和36个月 actuarial 局部控制率分别为96.8%(95%CI 95.8%-97.8%)和89.0%(95%CI 87.0%-91.1%)。
- 单变量Cox回归中BEDave是局部复发风险的最佳预测因子,基于BEDmin的模型证据支持明显较少。
- 单变量逻辑回归中基于BEDave的模型也表现最佳。
- 快速节俭树多变量分类显示BEDmax是最重要预测因子,其次为BEDave。
关键数值与推荐
- 12个月局部控制率96.8%(95%CI 95.8%-97.8%),36个月局部控制率89.0%(95%CI 87.0%-91.1%)。
- 单变量Cox回归中BEDave为局部复发风险最佳预测因子,BEDmin模型证据支持明显较少。
- 快速节俭树多变量分类中BEDmax为最重要预测因子,其次为BEDave。
临床怎么用
- BEDave与大体肿瘤体积平均剂量高度相关,后者或可作为处方目标。
- 可更重视达到足够高的大体肿瘤体积平均剂量,而非PTV覆盖剂量,该概念需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Large variation regarding prescription and dose inhomogeneity exists in stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer. The aim of this modeling study was to identify which dose metric correlates best with local tumor control probability to make recommendations regarding SBRT prescription. METHODS AND MATERIALS: We combined 2 retrospective databases of patients with non-small cell lung cancer, yielding 1500 SBRT treatments for analysis. Three dose parameters were converted to biologically effective doses (BEDs): (1) the (near-minimum) dose prescribed to the planning target volume (PTV) periphery (yielding BEDmin); (2) the (near-maximum) dose absorbed by 1% of the PTV (yielding BEDmax); and (3) the average between near-minimum and near-maximum doses (yielding BEDave). These BED parameters were then correlated to the risk of local recurrence through Cox regression. Furthermore, BED-based prediction of local recurrence was attempted by logistic regression and fast and frugal trees. Models were compared using the Akaike information criterion. RESULTS: There were 1500 treatments in 1434 patients; 117 tumors recurred locally. Actuarial local control rates at 12 and 36 months were 96.8% (95% confidence interval, 95.8%-97.8%) and 89.0% (87.0%-91.1%), respectively. In univariable Cox regression, BEDave was the best predictor of risk of local recurrence, and a model based on BEDmin had substantially less evidential support. In univariable logistic regression, the model based on BEDave also performed best. Multivariable classification using fast and frugal trees revealed BEDmax to be the most important predictor, followed by BEDave. CONCLUSIONS: BEDave was generally better correlated with tumor control probability than either BEDmax or BEDmin. Because the average between near-minimum and near-maximum doses was highly correlated to the mean gross tumor volume dose, the latter may be used as a prescription target. More emphasis could be placed on achieving sufficiently high mean doses within the gross tumor volume rather than the PTV covering dose, a concept needing further validation.
引用
- Klement RJ, Sonke JJ, Allgäuer M, et al. Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments. Int J Radiat Oncol Biol Phys. 2020. PMID: 32188579. doi:10.1016/j.ijrobp.2020.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。